Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Revenue

Guizhou Sanli Pharmaceutical Co.,Ltd had revenue of 381.73M CNY in the quarter ending March 31, 2026, a decrease of -6.57%. This brings the company's revenue in the last twelve months to 1.68B, down -21.35% year-over-year. In the year 2025, Guizhou Sanli Pharmaceutical Co.,Ltd had annual revenue of 1.70B, down -20.59%.

• Revenue (ttm): 1.68B
• Revenue Growth: -21.35%
• P/S Ratio: 3.02
• Revenue / Employee: 888.17K
• Employees: 2,852
• Market Cap: 5.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.70B	-441.54M	-20.59%
Dec 31, 2024	2.14B	509.41M	31.16%
Dec 31, 2023	1.63B	433.66M	36.10%
Dec 31, 2022	1.20B	262.35M	27.94%
Dec 31, 2021	938.97M	308.74M	48.99%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error